Literature DB >> 3900135

Interactions of insulin, insulinlike growth factor II, and platelet-derived growth factor in erythropoietic culture.

N Dainiak, S Kreczko.   

Abstract

To examine the influence of insulin and insulinlike growth factor (IGF) on erythropoiesis, we tested their effects in human bone marrow cultures prepared with biochemically defined medium or a platelet-poor plasma-derived serum (PDS) that was depleted of hormones by adsorption to activated charcoal. Erythroid colony formation was enhanced two- to threefold by 10 ng/ml of electrophoretically pure IGF-II and 100 ng/ml of highly purified insulin (P less than 0.05). Dose-response curves for IGF-II were parallel to and shifted by one to two orders of magnitude to the left relative to those for insulin. When added together to culture, IGF-II and insulin expressed additive activities. In contrast, their activities were synergistic with those of erythropoietin and burst-promoting activity. The erythropoietic actions of IGF-II and insulin were similar in PDS and whole blood serum (WBS) containing cultures. Furthermore, when added to cultures with electrophoretically pure platelet-derived growth factor, their respective activities were synergistic. We conclude that insulin and IGF-II potentiate human marrow erythropoiesis in vitro. Their activities appear to be mediated by a similar receptor or postreceptor system.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3900135      PMCID: PMC424030          DOI: 10.1172/JCI112079

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  33 in total

1.  Insulin stimulates erythroid colony formation independently of erythropoietin.

Authors:  A Kurtz; W Jelkmann; C Bauer
Journal:  Br J Haematol       Date:  1983-02       Impact factor: 6.998

Review 2.  Interactions of insulin and insulin-like growth factors (IGF) with endothelial cells.

Authors:  R S Bar
Journal:  Ann N Y Acad Sci       Date:  1982       Impact factor: 5.691

3.  Non-parallel evolution of metabolic and growth-promoting functions of insulin.

Authors:  G L King; C R Kahn
Journal:  Nature       Date:  1981-08-13       Impact factor: 49.962

4.  Platelet-derived growth factor promotes proliferation of erythropoietic progenitor cells in vitro.

Authors:  N Dainiak; G Davies; M Kalmanti; J Lawler; V Kulkarni
Journal:  J Clin Invest       Date:  1983-05       Impact factor: 14.808

5.  Insulin action.

Authors:  M P Czech
Journal:  Am J Med       Date:  1981-01       Impact factor: 4.965

6.  In vitro steroid sensitivity testing: a possible means to predict response to therapy in primary hypoproliferative anemia.

Authors:  N Dainiak; R Hoffman; A K Ritchey; V Floyd; M Callahan
Journal:  Am J Hematol       Date:  1980       Impact factor: 10.047

7.  Natural and biosynthetic insulin stimulates the growth of human erythroid progenitors in vitro.

Authors:  N Bersch; J E Groopman; D W Golde
Journal:  J Clin Endocrinol Metab       Date:  1982-12       Impact factor: 5.958

8.  Correlation of clinical and in vitro erythropoietic responses to androgens in renal failure.

Authors:  M Kalmanti; N Dainiak; J Martino; M Dewey; V Kulkarni; D Howard
Journal:  Kidney Int       Date:  1982-10       Impact factor: 10.612

9.  Radioimmunological determination of insulinlike growth factors I and II in normal subjects and in patients with growth disorders and extrapancreatic tumor hypoglycemia.

Authors:  J Zapf; H Walter; E R Froesch
Journal:  J Clin Invest       Date:  1981-11       Impact factor: 14.808

10.  Nutrition and somatomedin. XIII. Usefulness of somatomedin-C in nutritional assessment.

Authors:  T G Unterman; R M Vazquez; A J Slas; P A Martyn; L S Phillips
Journal:  Am J Med       Date:  1985-02       Impact factor: 4.965

View more
  12 in total

1.  Intracellular regulation of the production and release of human erythroid-directed lymphokines.

Authors:  N Dainiak; S Sorba
Journal:  J Clin Invest       Date:  1991-01       Impact factor: 14.808

2.  Insulin-driven erythropoiesis may underlie impairment of erythrocyte deformability in hyperinsulinaemic, hyperglycaemic ob/ob-mice.

Authors:  K G Engström; K Grankvist; I B Täljedal
Journal:  Diabetologia       Date:  1990-03       Impact factor: 10.122

3.  Enhancement of human granulopoiesis in vitro by biosynthetic insulin-like growth factor I/somatomedin C and human growth hormone.

Authors:  S Merchav; I Tatarsky; Z Hochberg
Journal:  J Clin Invest       Date:  1988-03       Impact factor: 14.808

4.  Accurate processing and secretion in the baculovirus expression system of an erythroid-cell-stimulating factor consisting of a chimaera of insulin-like growth factor II and an insect insulin-like peptide.

Authors:  L F Congote; Q Li
Journal:  Biochem J       Date:  1994-04-01       Impact factor: 3.857

5.  Regulated production of a pleiotropic cytokine-platelet-derived growth factor--by differentiating erythroid cells in vitro and in vivo.

Authors:  J C Keutzer; A J Sytkowski
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-23       Impact factor: 11.205

6.  Treatment with insulin analogs, especially Glargine and Lispro, associates with better renal function and higher hemoglobin levels in Type 1 diabetic patients with impaired kidney function.

Authors:  Christoph Hasslacher; Felix Kulozik; Justo Lorenzo Bermejo
Journal:  Ther Adv Endocrinol Metab       Date:  2016-05-15       Impact factor: 3.565

7.  Regulation of insulin-like growth factor II receptors by growth hormone and insulin in rat adipocytes.

Authors:  P Lönnroth; K Assmundsson; S Edén; G Enberg; I Gause; K Hall; U Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

8.  Human colony-forming units-erythroid do not require accessory cells, but do require direct interaction with insulin-like growth factor I and/or insulin for erythroid development.

Authors:  K Sawada; S B Krantz; E N Dessypris; S T Koury; S T Sawyer
Journal:  J Clin Invest       Date:  1989-05       Impact factor: 14.808

9.  Growth factor-dependent inhibition of normal hematopoiesis by N-ras antisense oligodeoxynucleotides.

Authors:  T Skorski; C Szczylik; M Z Ratajczak; L Malaguarnera; A M Gewirtz; B Calabretta
Journal:  J Exp Med       Date:  1992-03-01       Impact factor: 14.307

10.  Association between erythrocyte parameters and metabolic syndrome in urban Han Chinese: a longitudinal cohort study.

Authors:  Shuo Wu; Haiyan Lin; Chengqi Zhang; Qian Zhang; Dongzhi Zhang; Yongyuan Zhang; Wenjia Meng; Zhenxin Zhu; Fang Tang; Fuzhong Xue; Yanxun Liu
Journal:  BMC Public Health       Date:  2013-10-21       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.